 |
Human cytomegalovirus immunoglobulin |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of congenital cytomegalovirus (CMV) infection following primary CMV infection in pregnant women |
| USA Market Approval | USA |
| USA Designation Date | 2006-12-20 00:00:00 |
| Sponsor | Biotest Pharmaceuticals Corporation's (BPC);901 Yamato Road, Suite 101;Boca Raton, Florida, 33431 |
